Wintest
6721
Ridge-i
5572
D. Western Therapeutics Institute
4576
River Eletec
6666
Forside
2330
JP Stock MarketDetailed Quotes
6869 Sysmex
- 2961.5
- +41.0+1.40%
20min DelayTrading Dec 16 14:20 JST
1.86TMarket Cap37.37P/E (Static)
2973.5High2900.5Low765.10KVolume2928.0Open2920.5Pre Close2.25BTurnover3236.052wk High0.17%Turnover Ratio629.38MShares2138.052wk Low85.62EPS TTM1.34TFloat Cap5241.6Historical High37.37P/E (Static)450.99MShs Float86.9Historical Low79.24EPS LYR2.50%Amplitude29.00Dividend TTM4.19P/B100Lot Size0.98%Div YieldTTM
Sysmex Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.40%111.95B | 12.43%461.51B | 20.78%134.99B | 8.69%113.83B | 8.66%117.35B | 10.84%95.35B | 12.84%410.5B | 6.56%111.76B | 16.17%104.72B | 20.81%107.99B |
| Cost of revenue | 15.50%51.91B | 12.65%219.01B | 27.15%64.26B | 9.66%53.07B | 8.25%56.74B | 4.35%44.94B | 12.25%194.42B | -2.18%50.54B | 13.62%48.39B | 26.44%52.42B |
| Gross profit | 19.11%60.04B | 12.22%242.5B | 15.53%70.72B | 7.87%60.76B | 9.05%60.61B | 17.33%50.41B | 13.38%216.08B | 15.05%61.22B | 18.44%56.33B | 15.94%55.58B |
| Operating expense | 16.60%43.3B | 15.62%161.9B | 12.14%44.34B | 15.00%40.37B | 19.64%40.06B | 16.37%37.13B | 13.69%140.03B | 12.49%39.54B | 11.62%35.1B | 13.58%33.48B |
| Selling and administrative expenses | 19.46%36.02B | 19.07%133.8B | 23.13%37.95B | 16.41%33.26B | 16.60%32.44B | 19.84%30.15B | 19.25%112.37B | 16.44%30.82B | 22.91%28.57B | 22.23%27.83B |
| -General and administrative expense | 19.46%36.02B | 19.07%133.8B | 23.13%37.95B | 16.41%33.26B | 16.60%32.44B | 19.84%30.15B | 19.25%112.37B | 16.44%30.82B | 22.91%28.57B | 22.23%27.83B |
| Research and development costs | 3.16%7.36B | 1.10%31.4B | -9.04%8.18B | 8.91%8.21B | 3.53%7.88B | 3.11%7.13B | 15.96%31.06B | 6.22%9B | 12.38%7.54B | 24.46%7.61B |
| Other operating expenses | 3.97%157M | 28.37%905M | -550.00%-81M | 143.89%539M | 37.85%295M | -39.84%151M | -80.18%705M | -96.41%18M | -87.64%221M | -81.86%214M |
| Total other operating income | -22.00%234M | 2.44%4.2B | 481.29%1.71B | 33.66%1.63B | -74.15%561M | -28.06%300M | 191.20%4.1B | 2.08%294M | 325.44%1.22B | 272.85%2.17B |
| Operating profit | 26.10%16.74B | 5.98%80.6B | 21.71%26.38B | -3.93%20.39B | -7.01%20.55B | 20.12%13.28B | 12.80%76.05B | 20.04%21.68B | 31.77%21.22B | 19.73%22.1B |
| Net non-operating interest income (expenses) | -149.67%-377M | -106.12%-1.45B | -863.64%-530M | -264.19%-539M | -166.28%-229M | 63.44%-151M | -95.82%-703M | 71.94%-55M | -148M | -17.81%-86M |
| Non-operating interest income | -15.81%213M | 8.57%937M | -12.34%206M | -23.71%148M | 17.50%329M | 64.29%253M | 56.91%863M | 125.96%235M | 1.04%194M | 85.43%280M |
| Non-operating interest expense | 46.04%590M | 52.36%2.39B | 153.79%736M | 100.88%687M | 52.46%558M | -28.75%404M | 72.28%1.57B | -3.33%290M | 78.13%342M | 63.39%366M |
| Net investment income | 61.68%1.38B | 138.54%516M | 157.60%326M | 70.70%-1.16B | 94.88%495M | -70.79%856M | -257.53%-1.34B | -238.73%-566M | -956.93%-3.96B | 194.42%254M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 6.21%-770M | 2.53%-2.85B | 54.70%-467M | -47.18%-886M | -18.90%-673M | -13.55%-821M | 17.92%-2.92B | 30.20%-1.03B | 6.96%-602M | 27.53%-566M |
| Special income (charges) | 6.67%-2.21B | -2.37B | ||||||||
| Less:Write off | ---- | -6.67%2.21B | ---- | ---- | ---- | ---- | --2.37B | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 29.02%16.98B | 8.57%74.6B | 33.10%23.5B | 7.81%17.8B | -7.18%20.14B | 2.44%13.16B | 6.79%68.71B | 5.14%17.66B | 3.69%16.51B | 25.20%21.7B |
| Income tax | 30.38%6B | 8.00%24.83B | 16.75%8.21B | 2.63%5.47B | 13.45%6.55B | -5.27%4.6B | 13.39%22.99B | 36.58%7.03B | 0.17%5.33B | 9.61%5.77B |
| Net income | 28.30%10.98B | 8.86%49.77B | 43.93%15.29B | 10.28%12.33B | -14.67%13.59B | 7.11%8.56B | 3.75%45.73B | -8.77%10.62B | 5.44%11.18B | 32.00%15.93B |
| Net income continuous operations | 28.29%10.98B | 8.86%49.77B | 43.92%15.29B | 10.28%12.33B | -14.66%13.59B | 7.12%8.56B | 3.75%45.73B | -8.77%10.62B | 5.45%11.18B | 32.00%15.93B |
| Noncontrolling interests | 20.34%-47M | 328.81%135M | 409.09%112M | 558.33%55M | 187.10%27M | -59.46%-59M | -180.95%-59M | -77.08%22M | 25.00%-12M | 26.19%-31M |
| Net income attributable to the company | 27.97%11.03B | 8.42%49.64B | 43.17%15.18B | 9.67%12.28B | -15.00%13.57B | 7.35%8.62B | 3.84%45.78B | -8.20%10.6B | 5.39%11.19B | 31.79%15.96B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | -1M | 0 | 0 | -1M | 0 |
| Net income attributable to common stockholders | 27.95%11.03B | 8.42%49.64B | 43.17%15.18B | 9.67%12.28B | -15.00%13.57B | 7.36%8.62B | 3.84%45.78B | -8.21%10.6B | 5.40%11.2B | 31.79%15.96B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 28.81%17.69 | 8.68%79.27 | 43.95%24.3033 | 10.00%19.62 | -15.04%21.6033 | 7.35%13.7333 | 3.77%72.94 | -8.24%16.8833 | 5.36%17.8367 | 31.65%25.4267 |
| Diluted earnings per share | 28.90%17.69 | 8.68%79.24 | 43.97%24.2967 | 10.02%19.6167 | -15.02%21.5967 | 7.30%13.7233 | 3.91%72.91 | -8.16%16.8767 | 5.52%17.83 | 31.90%25.4133 |
| Dividend per share | 0 | 5.00%28 | 5.00%14 | 0 | 5.00%14 | 0 | 5.26%26.6667 | 2.56%13.3333 | 0 | 8.11%13.3333 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
